Sophia Karandashova1, Apparao Kummarapurugu2, Shuo Zheng2, Le Kang3, Shumei Sun3, Bruce K Rubin2, Judith A Voynow2. 1. Center for Clinical and Translational Research at Virginia Commonwealth University (VCU), Richmond, Virginia. 2. Division of Pediatric Pulmonology, Children's Hospital of Richmond at VCU, Richmond, Virginia. 3. Department of Biostatistics, VCU, Richmond, Virginia.
Abstract
INTRODUCTION: Sphingolipids are associated with the regulation of pulmonary inflammation. Although sphingolipids have been investigated in the context of cystic fibrosis (CF), the focus has been on loss of CF transmembrane conductance regulator (CFTR) function in mice, and in CF human lung epithelial cell lines. The sphingolipid content of CF sputum and the potential link between ceramide and airway inflammation in CF remain relatively unexplored. METHODS: Fifteen patients with CF provided two spontaneously expectorated sputum samples, one collected during a hospitalization for an acute pulmonary exacerbation and one from an outpatient visit at a time of clinical stability. Sputum was processed, and the supernatant assessed for active neutrophil elastase (NE) using a chromogenic microplate assay and sphingolipid content using reverse phase high-performance liquid chromatography/electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS). Relevant demographic data including age, sex, CF genotype, FEV1 % predicted, and sputum bacteriology were assessed as possible modifying factors that could influence the correlation between NE and sputum sphingolipids. Data were analyzed for linear correlation, with statistical significance pre-defined as P < 0.05. RESULTS: There was a significant association between the concentration of active NE and ceramide, sphingomyelin, and monohexosylceramide moieties as well as sphingosine-1-phosphate. The presence of Methicillin-resistant Staphylococcus aureus (MRSA), FEV1 % predicted, and female gender further strengthened the association of NE and sphingolipids, but Pseudomonas aeruginosa had no effect on the association between NE and sphingolipids. CONCLUSIONS: These data suggest that NE may increase pro-inflammatory sphingolipid signaling, and the association is strengthened in female patients and patients with MRSA.
INTRODUCTION:Sphingolipids are associated with the regulation of pulmonary inflammation. Although sphingolipids have been investigated in the context of cystic fibrosis (CF), the focus has been on loss of CF transmembrane conductance regulator (CFTR) function in mice, and in CF human lung epithelial cell lines. The sphingolipid content of CF sputum and the potential link between ceramide and airway inflammation in CF remain relatively unexplored. METHODS: Fifteen patients with CF provided two spontaneously expectorated sputum samples, one collected during a hospitalization for an acute pulmonary exacerbation and one from an outpatient visit at a time of clinical stability. Sputum was processed, and the supernatant assessed for active neutrophil elastase (NE) using a chromogenic microplate assay and sphingolipid content using reverse phase high-performance liquid chromatography/electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS). Relevant demographic data including age, sex, CF genotype, FEV1 % predicted, and sputum bacteriology were assessed as possible modifying factors that could influence the correlation between NE and sputum sphingolipids. Data were analyzed for linear correlation, with statistical significance pre-defined as P < 0.05. RESULTS: There was a significant association between the concentration of active NE and ceramide, sphingomyelin, and monohexosylceramide moieties as well as sphingosine-1-phosphate. The presence of Methicillin-resistant Staphylococcus aureus (MRSA), FEV1 % predicted, and female gender further strengthened the association of NE and sphingolipids, but Pseudomonas aeruginosa had no effect on the association between NE and sphingolipids. CONCLUSIONS: These data suggest that NE may increase pro-inflammatory sphingolipid signaling, and the association is strengthened in female patients and patients with MRSA.
Authors: Nicole Mayer-Hamblett; Moira L Aitken; Frank J Accurso; Richard A Kronmal; Michael W Konstan; Jane L Burns; Scott D Sagel; Bonnie W Ramsey Journal: Am J Respir Crit Care Med Date: 2007-01-18 Impact factor: 21.405
Authors: Judith A Voynow; Bernard M Fischer; David E Malarkey; Lauranell H Burch; Teresa Wong; Malinda Longphre; Samuel B Ho; W Michael Foster Journal: Am J Physiol Lung Cell Mol Physiol Date: 2004-07-23 Impact factor: 5.464
Authors: Benjamin J Pettus; Alicja Bielawska; Sarah Spiegel; Patrick Roddy; Yusuf A Hannun; Charles E Chalfant Journal: J Biol Chem Date: 2003-07-10 Impact factor: 5.157
Authors: Irina Petrache; Terry R Medler; Amy T Richter; Krzysztof Kamocki; Ugonma Chukwueke; Lijie Zhen; Yuan Gu; Jeremy Adamowicz; Kelly S Schweitzer; Walter C Hubbard; Evgeny V Berdyshev; Giuseppe Lungarella; Rubin M Tuder Journal: Am J Physiol Lung Cell Mol Physiol Date: 2008-04-25 Impact factor: 5.464
Authors: Claudine Guilbault; Juan B De Sanctis; Gabriella Wojewodka; Zienab Saeed; Claude Lachance; Thomas A A Skinner; Regina M Vilela; Stan Kubow; Larry C Lands; Marian Hajduch; Elias Matouk; Danuta Radzioch Journal: Am J Respir Cell Mol Biol Date: 2007-07-26 Impact factor: 6.914
Authors: Volker Teichgräber; Martina Ulrich; Nicole Endlich; Joachim Riethmüller; Barbara Wilker; Cheyla Conceição De Oliveira-Munding; Anna M van Heeckeren; Mark L Barr; Gabriele von Kürthy; Kurt W Schmid; Michael Weller; Burkhard Tümmler; Florian Lang; Heike Grassme; Gerd Döring; Erich Gulbins Journal: Nat Med Date: 2008-03-30 Impact factor: 53.440
Authors: Hamed Horati; Hettie M Janssens; Camilla Margaroli; Mieke Veltman; Marta Stolarczyk; Matthew B Kilgore; Jeffrey Chou; Limin Peng; Harm A M W Tiddens; Joshua D Chandler; Rabindra Tirouvanziam; Bob J Scholte Journal: J Cyst Fibros Date: 2020-02-10 Impact factor: 5.482